Savara (SVRA) Change in Account Payables (2016 - 2017)
Savara's (SVRA) quarterly Change in Account Payables came in at -$127000.0 in Q1 2017, up 83.63% year-on-year from -$69159.3 in Q1 2016, and up 83.63% on a QoQ basis from -$776000.0 in Q1 2016.
Savara (SVRA) Change in Account Payables (2016 - 2017) Analysis & Trends
Savara (SVRA) has 2 years of Change in Account Payables data on file, last reported at -$127000.0 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | -127,000.00 |
| Mar 31, 2017 | -127,000.00 |
| Mar 31, 2016 | -776,000.00 |
| Mar 31, 2016 | -776,000.00 |